Literature DB >> 15255997

The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.

Patricia Robledo1, Victoria Mendizabal, Jordi Ortuño, Rafael de la Torre, Brigitte L Kieffer, Rafael Maldonado.   

Abstract

The involvement of mu-opioid receptors in the rewarding properties of MDMA was explored in mu-opioid receptor knockout mice using the conditioning place preference paradigm. The associated release of dopamine in the nucleus accumbens was investigated by in vivo microdialysis. A significant rewarding effect of MDMA (10 mg/kg, i.p.) was observed in both wild-type and mu-opioid receptor knockout mice. MDMA (10 mg/kg, i.p.) also induced similar increases in dopamine and decreases in 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens dialysates of both wild-type and mu-opioid receptor knockout mice. No significant differences in basal levels of dopamine, 3,4-dihydroxyphenylacetic or homovanillic acids between wild-type and mu-opioid receptor knockout mice were observed. In summary, the present results suggest that, in contrast to what has been reported for other drugs of abuse such as opioids, ethanol, nicotine and Delta(9)-tetrahydrocannabinol, mu-opioid receptors do not play a major role in the rewarding properties of MDMA. These differences could be due to distinct mechanisms controlling dopamine release in the nucleus accumbens and suggest that the effects of MDMA on dopaminergic neurons are independent of micro -opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255997     DOI: 10.1111/j.1460-9568.2004.03532.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  A reliable model of intravenous MDMA self-administration in naïve mice.

Authors:  José Manuel Trigo; Fany Panayi; Guadalupe Soria; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

2.  Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

Authors:  Auxiliadora Aracil-Fernández; José M Trigo; María S García-Gutiérrez; Antonio Ortega-Álvaro; Alexander Ternianov; Daniela Navarro; Patricia Robledo; Pere Berbel; Rafael Maldonado; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

Review 3.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

Review 4.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

5.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

Review 6.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

7.  Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion.

Authors:  Maria Elena Avale; Philippe Faure; Stéphanie Pons; Patricia Robledo; Thierry Deltheil; Denis J David; Alain M Gardier; Rafael Maldonado; Sylvie Granon; Jean-Pierre Changeux; Uwe Maskos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

8.  Behavioural and neurochemical effects of combined MDMA and THC administration in mice.

Authors:  Patricia Robledo; Jose M Trigo; Fany Panayi; Rafael de la Torre; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2007-08-08       Impact factor: 4.530

Review 9.  15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.

Authors:  Pauline Charbogne; Brigitte L Kieffer; Katia Befort
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

10.  Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.

Authors:  Luisa Ponzoni; Daniela Braida; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2016-06-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.